Multidimensional Analysis of Parent-Perceived Quality of Life in Children with Cerebral Palsy: A Cross-Sectional Study
Abstract
Highlights What are the main findings? • Parents of children using AFOs, receiving botulinum toxin, undergoing pelvic surgery, or engaging in intensive physical therapy (>2 h/week) reported significantly lower scores in multiple domains of quality of life, including “Social well-being”, “Emotional well-being”, “Feelings about functioning”, and “Family health”.• The ‘Feelings about Functioning’ domain was 62% explained by motor and activity-related measures (GMFM-88, PEDI-CAT Activity, and PEDI-CAT Social/Cognitive), with PEDI-CAT Activity emerging as the strongest predictor. What are the implications of the main findings? • The association between specific medical interventions and lower quality-of-life scores underscores the need for holistic care strategies that address psychosocial well-being alongside physical treatment in children with CP.• Identifying PEDI-CAT Activity as the strongest predictor of the ‘Feelings about Functioning’ domain highlights the importance of prioritizing functional activity in rehabilitation programs to enhance perceived quality of life. Abstract Background/Objectives: To analyze the parent-perceived quality of life (QoL) in children with cerebral palsy (CP) and to study the relationship between sociodemographic and clinical factors and this perception, under the perspective of the International Classification of Functioning, Disability and Health (ICF). Methods: A cross-sectional study was conducted with 95 participants (ages 5–19 years) with…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 95 participants or records.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.